ArticlePharmaceutics2023

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease.

Marina Beraza-Millor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.